M&A Deal Summary

Lumos Acquires Lumos Pharma

On September 30, 2019, Lumos acquired life science company Lumos Pharma

Acquisition Highlights
  • This is Lumos’ 1st transaction in the Life Science sector.
  • This is Lumos’ 1st transaction in the United States.
  • This is Lumos’ 1st transaction in Texas.

M&A Deal Summary

Date 2019-09-30
Target Lumos Pharma
Sector Life Science
Buyer(s) Lumos
Deal Type Merger

Target

Lumos Pharma

Austin, Texas, United States
Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare and neglected diseases.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Lumos

Austin, Texas, United States

Category Company
Founded 2011
Sector Life Science
Employees29
DESCRIPTION

Lumos is a clinical-stage biopharmaceutical company focused on developing novel oncology product candidates to improve the lives of patients with cancer where treatment options are limited. Lumos was founded in 2011 and is based in Austin, Texas.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Texas M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2019 M&A 1 of 1